Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
10 Apr, 26
ACC 2026
Key Sessions on hypertension, presented at the American College of Cardiology (ACC) 2026 conference held in New Orelans, LA from 28th March to 30th March 2026.
10 Apr, 26ACC 2026
Key Sessions on cardiac arrhythmias, presented at the American College of Cardiology (ACC) 2026 conference held in New Orelans, LA from 28th March to 30th March 2026
15 Apr, 26Lancet Psychiatry
- 36% (93/256) of patients with first episode psychosis relapsed within 2 years of follow up.
- Stressful life events after psychosis onset increased relapse risk (HR 2.60, 95% CI 1.63–4.16)
- Each additional stressful event increased relapse risk (HR 1.36) and relapse duration (IRR 1.52)
- Stressful events preceding relapse raised relapse odds (OR 3.82)
15 Apr, 26BMC Infect Dis.
- Adults ≥18 y had much higher mod–sev HAV than children (69.5% vs 7.7%; aOR 8.42, 95% CI 3.21–22.08)
- Adults had higher hospitalisation rates and ALT/AST levels, despite similar viral loads
- Delayed exposure showed stronger CD8⁺ IFN γ ELISPOT responses and higher IFN γ/TNF α
- Kerala surveillance (34,118 cases) supports childhood HAV vaccination to prevent severe adult disease.
10 Apr, 26J Asthma
- Responsiveness was better detected by both Asthma Clinical Score (ACS) and Pediatric Respiratory Assessment Measure (PRAM) in normal‑weight vs obese asthmatic children; ACS 34% vs 23%, PRAM 28% vs 3.7%
- Obesity reduced interrater reliability and responsiveness of both scores but improved prediction of hospitalization
- Obese children were at a higher risk of receiving more intensive treatments.
10 Apr, 26Obesity.
- As per the analysis of 15 RCTs (14,059 adults non-diabetics), all GLP 1 agents reduced weight vs placebo
- Tirzepatide showed greatest efficacy: max dose yielded largest loss, followed by 15 mg, 10 mg, semaglutide 2.4 mg, tirzepatide 5 mg, & liraglutide 3 mg
- Adverse events were higher with tirzepatide & semaglutide but not with liraglutide
- Tirzepatide proved to be the most effective FDA-approved option for weight lo...
Featured
31 Mar, 26
Key Trials
30 Mar, 26
30 Mar, 26
Key Trials
30 Mar, 26
30 Mar, 26
